143 related articles for article (PubMed ID: 14558349)
1. [Experimental systemic enzyme therapy of gouty and primary glomerulonephritis].
Mukhin IV; Nikolenko VIu
Eksp Klin Farmakol; 2003; 66(4):32-5. PubMed ID: 14558349
[TBL] [Abstract][Full Text] [Related]
2. [Systemic enzyme therapy of experimental gout glomerulonephritis].
Ignatenko GA; Mukhin IV
Patol Fiziol Eksp Ter; 2004; (4):26-8. PubMed ID: 15568502
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of dyslipoproteinemia by systemic enzyme therapy in experimental glomerulonephritis].
Mukhin IV
Patol Fiziol Eksp Ter; 2002; (4):27-8. PubMed ID: 12638428
[TBL] [Abstract][Full Text] [Related]
4. [Systemic enzymotherapy in the combined treatment of infectious endocarditis in drug addicts].
Ulanova VI; Mazurov VI
Klin Med (Mosk); 2011; 89(2):53-5. PubMed ID: 21574445
[TBL] [Abstract][Full Text] [Related]
5. [The pathogenetic basis for and clinical use of systemic enzyme therapy in traumatology and orthopedics].
Neverov VA; Klimov AV
Vestn Khir Im I I Grek; 1999; 158(1):41-4. PubMed ID: 10491833
[TBL] [Abstract][Full Text] [Related]
6. [Efficiency of a complex preventive therapy including wobenzym in pregnant women with chronic pyelonephritis and glomerulonephritis].
Zufarova ShA
Lik Sprava; 2010; (3-4):59-62. PubMed ID: 21265123
[TBL] [Abstract][Full Text] [Related]
7. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
Iakunina IA; Barskova VG; Nasonova VA
Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
[No Abstract] [Full Text] [Related]
8. [Gout as an unusual cause of pelvic pain].
van den Berge M; Vrugt B; Holt C; Smit CJ; Hoogenberg K
Ned Tijdschr Geneeskd; 2006 Jan; 150(3):151-4. PubMed ID: 16463619
[TBL] [Abstract][Full Text] [Related]
9. Case 1: differential diagnosis of an acute gouty attack.
Weaver AL
Am J Med; 2006 Nov; 119(11 Suppl 1):S2-3. PubMed ID: 17059907
[No Abstract] [Full Text] [Related]
10. Treatment of acute gout in hospitalized patients.
Petersel D; Schlesinger N
J Rheumatol; 2007 Jul; 34(7):1566-8. PubMed ID: 17610315
[TBL] [Abstract][Full Text] [Related]
11. [Chronic gout. Case report of a severe course of disease].
Boxberger F; Harsch IA; Brueckl WM; Hautmann M; Baum U; Hahn EG; Wein A
Med Klin (Munich); 2003 Nov; 98(11):646-7. PubMed ID: 14631540
[No Abstract] [Full Text] [Related]
12. Updates in the management of gout.
Keith MP; Gilliland WR
Am J Med; 2007 Mar; 120(3):221-4. PubMed ID: 17349440
[TBL] [Abstract][Full Text] [Related]
13. Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency.
Edwards NL
Am J Med; 2006 Nov; 119(11 Suppl 1):S29-31. PubMed ID: 17059911
[No Abstract] [Full Text] [Related]
14. [Experimental evaluation of the wound healing dynamics].
Minaev SV
Vestn Khir Im I I Grek; 2003; 162(4):57-62. PubMed ID: 14569780
[TBL] [Abstract][Full Text] [Related]
15. Metabolic diseases: gout.
Falasca GF
Clin Dermatol; 2006; 24(6):498-508. PubMed ID: 17113968
[TBL] [Abstract][Full Text] [Related]
16. Febuxostat (Uloric) for chronic treatment of gout.
Med Lett Drugs Ther; 2009 May; 51(1312):37-8. PubMed ID: 19448587
[TBL] [Abstract][Full Text] [Related]
17. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.
Riedel AA; Nelson M; Joseph-Ridge N; Wallace K; MacDonald P; Becker M
J Rheumatol; 2004 Aug; 31(8):1575-81. PubMed ID: 15290738
[TBL] [Abstract][Full Text] [Related]
18. [Antioxidant effect of wobenzym applied for patients with chronic glomerulonephritis].
Mukhin IV
Lik Sprava; 2007; (1-2):58-61. PubMed ID: 17684803
[TBL] [Abstract][Full Text] [Related]
19. Febuxostat versus allopurinol for gout.
Gelber AC
N Engl J Med; 2006 Apr; 354(14):1532-3; author reply 1532-3. PubMed ID: 16602151
[No Abstract] [Full Text] [Related]
20. [Gout].
Gröbner W; Zöllner N
Z Rheumatol; 2004 Feb; 63(1):2-9. PubMed ID: 14991273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
